Ozempic, Wegovy may be linked to risk of rare form of blindness: study

(The Hill) — Those who take Ozempic or Wegovy may have an increased risk of developing a rare form of blindness, though future research is needed to make a final determination, researchers in a new study said.
Published Wednesday in the medical journal JAMA Ophthalmology, the study analyzed more than 16,800 people in the Boston area over the past six years, none of whom initially had the eye condition, called nonarteritic anterior ischemic optic neuropathy (NAION).
NAOIN occurs when there